Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 45.5% decrease from the number of companies inspected in the previous year, when 11 companies received 12 inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected period worked in the Veterinary and Devices sectors.
There were five companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Amgen, Inc. | Devices | 01/17/2024 | No Action Indicated (NAI) |
| Black Radish Creamery, Ltd. | Food and Cosmetics | 05/21/2024 | No Action Indicated (NAI) |
| HW Martin & Son Company | Veterinary | 09/03/2024 | No Action Indicated (NAI) |
| Nat2, Inc. | Food and Cosmetics | 05/20/2024 | Voluntary Action Indicated (VAI) |
| Tri Technician Laboratories, LLC | Food and Cosmetics | 07/31/2024 | No Action Indicated (NAI) |
| Tufos To Go, LLC | Food and Cosmetics | 10/10/2024 | No Action Indicated (NAI) |
Alerts Sign-up